Gene · 10419
Papers3,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRMT5 inhibition disrupts detained intron splicing and impairs ATR signaling with increased DNA damage. | Commun Biol | 2026 | 42448898 | PubTator, text mining | PubMed |
| Toll-like receptor 9 arginine methylation promotes ferroptosis in prostate cancer through the NRF2/GPX4 signaling pathway. | Transl Androl Urol | 2026 | 42436792 | PubTator, text mining | PubMed |
| PRMT5 promotes psoriatic inflammation through mediating dimethylation of p65 in keratinocytes. | Mol Med | 2026 | 42432494 | PubTator, text mining | PubMed |
| MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation. | Oncogene | 2026 | 42432327 | PubTator, text mining | PubMed |
| Tumor-type specific methylation patterns of MTAP in human samples and cell lines. | Clin Epigenetics | 2026 | 42421155 | PubTator, text mining | PubMed |
| PRMT5-Dependent Stabilization of VPS34 Orchestrates Copper Trafficking to Shield Cancer Cells from Cuproptosis and Radiotherapy. | Adv Sci (Weinh) | 2026 | 42419369 | PubTator, text mining | PubMed |
| PRMT5 inhibition promotes cross-species spermatogonia expansion and suppresses differentiation. | Cell Regen | 2026 | 42410128 | PubTator, text mining | PubMed |
| Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights From a Large-Scale Real-World Chinese Cohort. | J Thorac Oncol | 2026 | 42409117 | PubTator, text mining | PubMed |
| Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer. | Clin Cancer Res | 2026 | 42405849 | PubTator, text mining | PubMed |
| ASFV pDP238L negatively regulates type I interferon production via inhibiting the methylation of TBK1. | Virology | 2026 | 42385548 | PubTator, text mining | PubMed |
| DNA damage response inhibitors in pancreatic cancer: progress and challenges. | Front Oncol | 2026 | 42376674 | PubTator, text mining | PubMed |
| Inhibition of PRMT5 sensitizes B-cell non-Hodgkin lymphoma cells to both intrinsic and extrinsic apoptotic cell death. | Blood Neoplasia | 2026 | 42376204 | PubTator, text mining | PubMed |
Focus on the Interactive Cooperation Among Mechanotransduction and Biochemical Processes in Pancreatic Ductal Adenocarcinoma Development and Possible Adjuvant Role of Retinoic Acid for Its Treatment: A Narrative Review. | Cancers (Basel) | 2026 | 42352466 | PubTator, text mining | PubMed |
| PRMT5 as a Key Driver of Stemness and Metastatic Potential in Triple-Negative Breast Cancer. | Biomolecules | 2026 | 42352382 | PubTator, text mining | PubMed |
| PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block? | Ann Oncol | 2026 | 42342327 | PubTator, text mining | PubMed |
| PCK2-Mediated PQBP1 Lactylation Promotes Asthmatic Inflammation through PRMT5 Inhibition. | Research (Wash D C) | 2026 | 42327952 | PubTator, text mining | PubMed |
| Targeting engulfment and cell motility 1 protein methylation attenuates M2 macrophage infiltration and boosts anti-PD-1 efficacy in colorectal cancer. | Gastroenterol Rep (Oxf) | 2026 | 42326870 | PubTator, text mining | PubMed |
Quantitative Global Proteomics of Formalin-Fixed Paraffin-Embedded Tumors Identifies Dimethylated G3BP1 at Arginine 460 as a Robust Pharmacodynamic Biomarker of Methylthioadenosine Phosphorylase-Selective Protein Arginine Methyltransferase 5 Inhibition. | J Proteome Res | 2026 | 42321016 | PubTator, text mining | PubMed |
| Structure-Guided Discovery of Novel Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitors. | ACS Med Chem Lett | 2026 | 42305212 | PubTator, text mining | PubMed |
| Peri-Implant Gingival Undifferentiated SWI/SNF Complex-Deficient Tumor with Molecularly Confirmed Biallelic SMARCA4 Inactivation: Diagnostic Pitfalls and Genomic Characterization. | Diagnostics (Basel) | 2026 | 42279597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10419/papers?page=3